Is nitrous oxide (N2O) safe for a woman with a low ejection fraction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrous Oxide Use in Women with Low Ejection Fraction

Nitrous oxide should be used with extreme caution or avoided entirely in women with low ejection fraction, particularly when ejection fraction is ≤25% or when pulmonary vascular resistance is elevated. 1, 2

Key Physiologic Concerns

Pulmonary Vascular Effects

  • Nitrous oxide increases pulmonary vascular resistance (PVR), with the magnitude of increase directly related to baseline PVR values. 1
  • In patients with elevated PVR (such as those with mitral valve stenosis), N2O caused marked increases in PVR from 357 to 530 dyn·s·cm⁻⁵ during fentanyl anesthesia, and from 351 to 451 dyn·s·cm⁻⁵ with halothane. 1
  • The preexisting PVR value is more important for predicting pulmonary vascular response to N2O than the choice of background anesthetic. 1

Reduced Efficacy in Low Ejection Fraction

  • In patients with ejection fraction ≤25%, inhaled nitric oxide (which shares some physiologic properties with N2O) fails to decrease systolic pulmonary artery pressure and may paradoxically increase it. 2
  • Left ventricular ejection fraction was the most explanatory independent variable (R² = 0.61, P = 0.0000) for predicting pulmonary pressure response. 2
  • Patients with LVEF >0.25 showed a decrease in systolic pulmonary artery pressure of -5.1 ± 5.2 mmHg, while those with LVEF ≤0.25 showed an increase of 0.8 ± 4.9 mmHg (P < 0.0000). 2

Clinical Decision Algorithm

When N2O May Be Considered (with intensive monitoring):

  • LVEF >40% 3
  • Normal pulmonary vascular resistance 1
  • No right ventricular dysfunction 1
  • No right coronary artery disease 1
  • Controlled heart failure status 4

When N2O Should Be Avoided:

  • LVEF ≤25% - high risk of paradoxical pulmonary pressure increase 2
  • Elevated pulmonary vascular resistance - marked PVR increases expected 1
  • Right ventricular dysfunction - poorly tolerated PVR increases 1
  • Severe pulmonary hypertension - risk of right heart decompensation 1
  • Uncontrolled heart failure - unpredictable hemodynamic effects 4

Alternative Analgesic Considerations

For patients at risk of hypercapnic respiratory failure or with significant cardiac dysfunction, Entonox (50:50 N2O/O2 mixture) should be avoided. 3

The concern is twofold: the high oxygen concentration may precipitate hypercapnia in susceptible patients, and the sedating effects combined with cardiac dysfunction create risk for hemodynamic instability. 3

Special Pathophysiologic Context in Heart Failure

Left Ventricular Adaptation

In patients with low ejection fraction, the mechanism matters: 3

  • If low EF is due to excessive afterload (inadequate hypertrophic response), corrective interventions may be more beneficial 3
  • If low EF is due to depressed contractility, the myocardium is less able to compensate for additional hemodynamic stress 3
  • The hypertrophied, failing heart has reduced coronary flow reserve and increased sensitivity to ischemic injury 3

Diastolic Dysfunction Considerations

Women with heart failure often have: 3

  • Increased LV wall thickness and diminished chamber compliance 3
  • Elevated end-diastolic pressure reflecting diastolic dysfunction 3
  • Critical dependence on atrial contraction for ventricular filling 3

Any intervention that increases pulmonary vascular resistance or alters loading conditions can precipitate acute decompensation in this vulnerable population. 3, 1

Critical Caveats

Monitoring Requirements

If N2O must be used despite low ejection fraction:

  • Continuous invasive hemodynamic monitoring is essential 1
  • Watch for increases in pulmonary artery pressure 1, 2
  • Monitor for signs of right heart strain 1
  • Be prepared for rapid discontinuation 1

Drug Interactions

Patients with heart failure are typically on guideline-directed medical therapy (ACE inhibitors, beta-blockers, diuretics) which should be continued unless severe hemodynamic instability is present. 5

The combination of N2O with these medications in the setting of low ejection fraction has not been well-studied, adding another layer of uncertainty. 5

Recreational Use Warning

Recreational N2O abuse poses serious cardiovascular risks, including acute myocardial infarction through hyperhomocysteinemia-induced hypercoagulation and vitamin B12 depletion. 6

This is particularly relevant for women of childbearing age who may use N2O recreationally and have undiagnosed cardiac dysfunction. 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.